Artal Group S.A. has filed its 13F form on May 17, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.86 Billion distributed in 113 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Lexicon Pharmaceuticals, Inc. with a value of $282M, Scholar Rock Holding Corp with a value of $200M, Kymera Therapeutics, Inc. with a value of $122M, Arrowhead Pharmaceuticals, Inc. with a value of $86.8M, and Morphic Holding, Inc. with a value of $77.9M.

Artal Group S.A. is based out at Luxembourg, N4

Below you can find more details about Artal Group S.A. portfolio as well as his latest detailed transactions.

Portfolio value $1.86 Billion
Healthcare: $1.78 Billion
ETFs: $23.7 Million
Consumer Cyclical: $21.8 Million
Technology: $20.7 Million
Financial Services: $5.25 Million
Real Estate: $3.78 Million
Consumer Defensive: $1.3 Million
Communication Services: $1.06 Million
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 113
  • Current Value $1.86 Billion
  • Prior Value $1.86 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 17, 2024
  • Form Type 13F-HR/A
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.